Hyperuricemia and progression of CKD in children and adolescents: The Chronic Kidney Disease in Children (CKiD) cohort study

American Journal of Kidney Diseases

Volumn 66, Issue 6, 2015, Pages 984-992

  Rodenbach, Kyle E ^a   Schneider, Michael F ^b   Furth, Susan L ^c   Moxey Mims, Marva M ^d   Mitsnefes, Mark M ^e   Weaver, Donald J ^f   Warady, Bradley A ^g   Schwartz, George J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f Levine Children s Hospital   (United States)

^g CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

adolescents; children; chronic kidney disease (CKD); CKD progression; CKiD (Chronic Kidney Disease in Children); disease trajectory; end stage renal disease (ESRD); glomerular filtration rate (GFR); hyperuricemia; pediatric kidney disease; renal function decline; renal replacement therapy (RRT); risk factor; urate; Uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; URIC ACID;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEINURIA; RENAL REPLACEMENT THERAPY; URIC ACID BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; RENAL INSUFFICIENCY, CHRONIC;

ADOLESCENT; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERURICEMIA; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; URIC ACID;

EID: 84948101032     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.06.015     Document Type: Article

References (41)

1. D.I. Feig Serum uric acid and the risk of hypertension and chronic kidney disease Curr Opin Rheumatol 26 2 2014 176 185
2. J. Dawson, P. Jeemon, L. Hetherington, and et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients Hypertension 62 1 2013 105 111
3. E. Krishnan, K.S. Akhras, H. Sharma, and et al. Serum urate and incidence of kidney disease among veterans with gout J Rheumatol 40 7 2013 1166 1172
4. Y. Ohta, T. Tsuchihashi, K. Kiyohara, and H. Oniki Increased uric acid promotes decline of the renal function in hypertensive patients: a 10-year observational study Intern Med 52 13 2012 1467 1472
5. A.B. Alper, W. Chen, L. Yau, S.R. Srinivasan, G.S. Berenson, and L.L. Hamm Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study Hypertension 45 1 2005 34 38
6. L.F. Loeffler, A. Navas-Acien, T.M. Brady, E.R. Miller, and J.J. Fadrowski Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006 Hypertension 59 4 2012 811 817
7. H.S. Goldstein, and P. Manowitz Relation between serum uric acid and blood pressure in adolescents Ann Hum Biol 20 5 1993 423 431
8. A.B. Gruskin The adolescent with essential hypertension Am J Kidney Dis 6 2 1985 86 90
9. D.P. Jones, P.A. Richey, B.S. Alpert, and R. Li Serum uric acid and ambulatory blood pressure in children with primary hypertension Pediatr Res 64 5 2008 556 561
10. S. Pan, C.H. He, Y.T. Ma, and et al. Serum uric acid levels are associated with high blood pressure in Chinese children and adolescents aged 10-15 years J Hypertens 32 5 2014 998 1004
11. E. Török, I. Gyarfas, and M. Csukas Factors associated with stable high blood pressure in adolescents J Hypertens 3 suppl 3 1985 S389 S390
12. F. Viazzi, L. Antolini, M. Giussani, and et al. Serum uric acid and blood pressure in children at cardiovascular risk Pediatrics 132 1 2013 e93 e99
13. F. Assadi Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension J Nephrol 27 1 2014 51 56
14. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JAMA 300 8 2008 924 932
15. B. Soletsky, and D.I. Feig Uric acid reduction rectifies prehypertension in obese adolescents Hypertension 60 5 2012 1148 1156
16. D.I. Feig, and R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 3 2003 247 252
17. M. Mazzali, J. Kanellis, L. Han, and et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol 282 6 2002 F991 F997
18. G.J. Schwartz, M.F. Schneider, P.S. Maier, and et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C Kidney Int 82 4 2012 445 453
19. A.S. Levey, L.A. Inker, K. Matsushita, and et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration Am J Kidney Dis 64 6 2014 821 835
20. B.A. Warady, A.G. Abraham, G.J. Schwartz, and et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the Chronic Kidney Disease in Children (CKiD) Cohort Am J Kidney Dis 65 6 2015 878 888
21. C. Cox, H. Chu, M.F. Schneider, and A. Muñoz Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution Stat Med 26 23 2007 4352 4374
22. S. Nguyen, H.K. Choi, R.H. Lustig, and C.Y. Hsu Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents J Pediatr 154 6 2009 807 813
23. C.Y. Hsu, C. Iribarren, C.E. McCulloch, and et al. Risk factors for end-stage renal disease: 25-year follow-up Arch Intern Med 169 2009 342 350
24. D.A. Colantonio, L. Kyriakopoulou, M.K. Chan, and et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children Clin Chem 58 5 2012 854 868
25. P. Gomez, C. Coca, C. Vargas, J. Acebillo, and A. Martinez Normal reference-intervals for 20 biochemical variables in healthy infants, children, and adolescents Clin Chem 30 3 1984 407 412
26. N. Jagarinec, Z. Flegar-Meštrić, B. Šurina, D. Vrhovski-Hebrang, and V. Preden-Kereković Pediatric reference intervals for 34 biochemical analytes in urban school children and adolescents Clin Chem Lab Med 36 5 1998 327 337
27. M. Kubota, A. Nagai, L. Tang, and M. Tokuda Investigation on hyperuricemia in children with obesity or various pediatric disorders Nucleosides Nucleotides Nucleic Acids 30 12 2011 1051 1059
28. G. Lockitch, A.C. Halstead, S. Albersheim, C. MacCallum, and G. Quigley Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer Clin Chem 34 8 1998 1622 1625
29. P. Ridefelt, M. Aldrimer, P.O. Rödöö, and et al. Population-based pediatric reference intervals for general clinical chemistry analytes on the Abbott Architect ci8200 instrument Clin Chem Lab Med 50 5 2012 845 851
30. M.F. Burritt, J.M. Slockbower, R.W. Forsman, K.P. Offord, E.J. Bergstralh, and W.A. Smithson Pediatric reference intervals for 19 biologic variables in healthy children Mayo Clin Proc 65 3 1990 329 336
31. H.G. Langford, M.D. Blaufox, N.O. Borhani, and et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program Arch Intern Med 147 4 1987 645 649
32. M. Madero, M.J. Sarnak, X. Wang, and et al. Uric acid and long-term outcomes in CKD Am J Kidney Dis 53 5 2009 796 803
33. S.M. Cho, S.G. Lee, H.S. Kim, and J.H. Kim Establishing pediatric reference intervals for 13 biochemical analytes derived from normal subjects in a pediatric endocrinology clinic in Korea Clin Biochem 47 18 2014 268 271
34. S.M. Clifford, A.M. Bunker, J.R. Jacobsen, and W.L. Roberts Age and gender specific pediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid Clin Chim Acta 412 9 2011 788 790
35. Y.P. Siu, K.T. Leung, M.K.H. Tong, and T.H. Kwan Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 47 1 2006 51 59
36. M.E. Suliman, R.J. Johnson, E. García-López, and et al. J-Shaped mortality relationship for uric acid in CKD Am J Kidney Dis 48 5 2006 761 771
37. M. Goicoechea, S.G. de Vinuesa, U. Verdalles, and et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Clin J Am Soc Nephrol 5 8 2010 1388 1393
38. B.S. Pai, G. Swarnalatha, R. Ram, and K.V. Dakshinamurty Allopurinol for prevention of progression of kidney disease with hyperuricemia Indian J Nephrol 23 4 2013 280 286
39. A. Momeni, S. Shahidi, S. Seirafian, S. Taheri, and S. Kheiri Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients Iran J Kidney Dis 4 2 2010 128 132
40. M. Kanbay, A. Ozkara, Y. Selcoki, and et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions Int Urol Nephrol 39 4 2007 1227 1233
41. M. Nakashima, T. Uematsu, K. Kosuge, and M. Kanamaru Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects Eur J Clin Pharmacol 42 3 1992 333 335